Gland Pharma Allots 3,739 Equity Shares Under ESOP Scheme 2025
Gland Pharma Ltd 路 Others (Uncategorized) 路 16 Nov 2026, 11:00 pm
Gland Pharma Allots 3,739 Equity Shares Under ESOP Scheme 2025 Gland Pharma Limited's ESOP Compensation Committee approved the allotment of 3,739 equity shares of face value Re. 1 each on 16th Nov'26 upon the exercise of stock options under the Gland Pharma Employee Stock Option Scheme 2025. The allotment comprises 2,474 shares exercised at Rs. 773.30 per share and 1,265 shares at Re. 1.00 per share. Following this issuance, the company's total issued and paid-up share capital increased to Rs. 16,50,14,593, consisting of 16,50,14,593 equity shares ranking pari passu with existing equity shares.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
- Unaudited Financial Results for the Quarter and half year ended September 30, 2026 路 06 Nov 2026
